 associ psychiatr manifest antibodi protein system lupu erythematosu purpos goal studi elev serum level antibodi protein anti-p antibodi neuropsychiatr manifest patient system lupu erythematosu sle addit experi characterist antibodi pathogen patient method larg number serum sampl patient sle control subject rheumat diseas normal individu time serum sampl patient sle presenc psychosi depress manifest central nervou system cn involv serum anti-p antibodi activ enzyme-link immunosorb assay synthet peptid major protein epitop result group normal individu mean SE igg anti-p activ individu valu SD mean similar result igm anti-p activ normal level sera patient rheumatoid arthriti patient variou pattern antinuclear anticytoplasm antibodi activ anti-p level patient sle overal patient sle elev level igg igm anti-p antibodi patient patient neuropsychiatr manifest frequenc posit test result natur cn involv frequenc patient sever depress psychosi patient nonpsychiatr neurolog diseas entir sle group odd ratio associ anti-p antibodi sever psychiatr manifest confid interv review patient sle sever psychiatr diseas patient antidepress medic level anti-p antibodi serial studi serum level anti-p antibodi activ psychiatr diseas activ manifest sle anti-p antibodi patient igg c-termin amino acid protein differ characterist patient psychiatr manifest pair serum cerebrospin fluid csf sampl patient activ neuropsychiatr diseas fraction total igg present anti-p activ csf serum conclus elev level autoantibodi c-termin region ribosom protein specif marker sle sever depress psychosi diseas assay reproduc sle-induc psychiatr diseas process